A Fading Thymus Hormone Made Cancer Immunotherapy Work Better in Older Mice

Researchers traced age-related inflammation to declining thymulin and found that restoring the hormone improved tumour control and response to checkpoint therapy in older mice, but no human treatment has yet been tested.